Literature DB >> 24611175

Perspective: Ill prepared for a pandemic.

Klaus Stöhr.   

Abstract

Mesh：

Substances：

Year:  2014        PMID： 24611175

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  3 in total

1.  Seasonal influenza vaccine provision in 157 countries (2004-2009) and the potential influence of national public health policies.

Authors:  Abraham Palache
Journal:  Vaccine       Date:  2011-10-21       Impact factor: 3.641

2.  Vaccine production capacity for seasonal and pandemic (H1N1) 2009 influenza.

Authors:  Nicolas Collin; Xavier de Radiguès
Journal:  Vaccine       Date:  2009-06-27       Impact factor: 3.641

3.  Synthetic generation of influenza vaccine viruses for rapid response to pandemics.

Authors:  Philip R Dormitzer; Pirada Suphaphiphat; Daniel G Gibson; David E Wentworth; Timothy B Stockwell; Mikkel A Algire; Nina Alperovich; Mario Barro; David M Brown; Stewart Craig; Brian M Dattilo; Evgeniya A Denisova; Ivna De Souza; Markus Eickmann; Vivien G Dugan; Annette Ferrari; Raul C Gomila; Liqun Han; Casey Judge; Sarthak Mane; Mikhail Matrosovich; Chuck Merryman; Giuseppe Palladino; Gene A Palmer; Terika Spencer; Thomas Strecker; Heidi Trusheim; Jennifer Uhlendorff; Yingxia Wen; Anthony C Yee; Jayshree Zaveri; Bin Zhou; Stephan Becker; Armen Donabedian; Peter W Mason; John I Glass; Rino Rappuoli; J Craig Venter
Journal:  Sci Transl Med       Date:  2013-05-15       Impact factor: 17.956
  3 in total
  7 in total

1.  Assessing and Managing the Risks of Potential Pandemic Pathogen Research.

Authors:  Daniel J Rozell
Journal:  MBio       Date:  2015-07-21       Impact factor: 7.867

2.  Mucosal Administration of Cycle-Di-Nucleotide-Adjuvanted Virosomes Efficiently Induces Protection against Influenza H5N1 in Mice.

Authors:  Thomas Ebensen; Jennifer Debarry; Gabriel K Pedersen; Paulina Blazejewska; Sebastian Weissmann; Kai Schulze; Kenneth C McCullough; Rebecca J Cox; Carlos A Guzmán
Journal:  Front Immunol       Date:  2017-09-28       Impact factor: 7.561

3.  Selective detections of single-viruses using solid-state nanopores.

Authors:  Akihide Arima; Makusu Tsutsui; Ilva Hanun Harlisa; Takeshi Yoshida; Masayoshi Tanaka; Kazumichi Yokota; Wataru Tonomura; Masateru Taniguchi; Mina Okochi; Takashi Washio; Tomoji Kawai
Journal:  Sci Rep       Date:  2018-11-02       Impact factor: 4.379

4.  FluChip-8G Insight: HA and NA subtyping of potentially pandemic influenza A viruses in a single assay.

Authors:  Evan Toth; Erica D Dawson; Amber W Taylor; Robert S Stoughton; Rebecca H Blair; James E Johnson; Amelia Slinskey; Ryan Fessler; Catherine B Smith; Sarah Talbot; Kathy Rowlen
Journal:  Influenza Other Respir Viruses       Date:  2019-10-13       Impact factor: 4.380

5.  Analyses of Safety Profile and Homologous Antibody Responses to a Mammalian Cell-Based, MF59-Adjuvanted, A/H5N1, Pandemic Influenza Vaccine across Four Phase II/III Clinical Trials in Healthy Children, Adults, and Older Adults.

Authors:  Eve Versage; Esther van Twuijver; Wim Jansen; Ad Theeuwes; Daphne Sawlwin; Matthew Hohenboken
Journal:  Vaccines (Basel)       Date:  2021-12-11

6.  Influenza Vaccine Manufacturing: Effect of Inactivation, Splitting and Site of Manufacturing. Comparison of Influenza Vaccine Production Processes.

Authors:  Theone C Kon; Adrian Onu; Laurentiu Berbecila; Emilia Lupulescu; Alina Ghiorgisor; Gideon F Kersten; Yi-Qing Cui; Jean-Pierre Amorij; Leo Van der Pol
Journal:  PLoS One       Date:  2016-03-09       Impact factor: 3.240

7.  Haemagglutinin displayed on the surface of Lactococcus lactis confers broad cross-clade protection against different H5N1 viruses in chickens.

Authors:  Han Lei; Tong Gao; Qianhong Cen; Xiaojue Peng
Journal:  Microb Cell Fact       Date:  2020-10-15       Impact factor: 5.328
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.